SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK (Q37071103)
Jump to navigation
Jump to search
scientific article published on 23 October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK |
scientific article published on 23 October 2008 |
Statements
1 reference
SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK (English)
1 reference
Kenneth C Anderson
1 reference
Tanyel Kiziltepe
1 reference
Hiroshi Ikeda
1 reference
Yutaka Okawa
1 reference
Teru Hideshima
1 reference
Paul Steed
1 reference
Sonia Vallet
1 reference
Steven Hall
1 reference
Ken Huang
1 reference
John Rice
1 reference
Amy Barabasz
1 reference
Brianna Foley
1 reference
Noopur Raje
1 reference
Hiroshi Yasui
1 reference
Sotaro Enatsu
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference